{"schema_version":"1","generated_at":"2026-10-29T04:56:44.181Z","data_as_of":null,"url":"https://www.findmykol.com/kol/elizabeth-wack","json_url":"https://www.findmykol.com/kol/elizabeth-wack/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"elizabeth-wack","name":"Elizabeth Wack","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Tucson","state":"AZ","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1598753865","openalex":"A5004872254"},"summary":"Elizabeth Wack is an Infectious Disease physician. OpenAlex indexes 7 publications with 306 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":7,"cited_by_count":306,"h_index":5,"latest_activity_year":2017,"source":"works"},"prescribing":{"data_year":2019,"areas_total":1,"areas_shown":1,"areas":[{"area":"Anti-infectives","share_pct":100,"classes_total":2,"classes":[{"class":"First-generation cephalosporins","setting":"prescribed","share_pct":53.8,"drugs":[{"name":"Cephalexin","share_pct":100}],"max_beneficiaries":null},{"class":"Azole Antifungal","setting":"prescribed","share_pct":46.2,"drugs":[{"name":"Fluconazole","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":8,"shown":5,"withheld":3,"matched_by":"OpenAlex author record","recent":[{"title":"Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis","year":2017,"journal":"Infection","source_url":"https://doi.org/10.1007/s15010-017-1029-9","status":"verified"},{"title":"Approach to Management of Coccidioidomycosis in Patients Receiving Inhibitors of Tumor Necrosis Factor-α","year":2016,"journal":"Infectious Diseases in Clinical Practice","source_url":"https://doi.org/10.1097/ipc.0000000000000466","status":"verified"},{"title":"The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis","year":2015,"journal":"Clinical Infectious Diseases","source_url":"https://doi.org/10.1093/cid/civ388","status":"verified"},{"title":"Coccidioidomycosis in immunocompromised patients","year":2002,"journal":"International Journal of Infectious Diseases","source_url":"https://doi.org/10.1016/s1201-9712(02)90281-x","status":"verified"},{"title":"Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance during 1 Year of Open-Label Experience","year":1999,"journal":"Antiviral Therapy","source_url":"https://doi.org/10.1177/135965359900400404","status":"verified"}],"source":"works"},"contact":{"address_1":"2001 W. ORANGE GROVE RD","address_2":"SUITE 404","city":"Tucson","state":"AZ","zip":"85704","phone":"520-989-0226","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1598753865","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"},{"name":"Myron Cohen","slug":"myron-cohen","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/myron-cohen","json_url":"https://www.findmykol.com/kol/myron-cohen/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":3}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-02-15","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019}},"methodology_url":"https://www.findmykol.com/about#methodology"}